Quantum Naturals India Profile
Key Indicators
- Authorised Capital ₹ 3.38 Cr
as on 17-07-2024
- Paid Up Capital ₹ 3.38 Cr
as on 17-07-2024
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 114.62%
(FY 2023)
- Profit -1041.95%
(FY 2023)
- Ebitda -653.93%
(FY 2023)
- Net Worth -429.00%
(FY 2023)
- Total Assets -36.57%
(FY 2023)
About Quantum Naturals India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.38 Cr and a paid-up capital of Rs 3.38 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gurmukh Ghuldu and Nirmal Ghuldu serve as directors at the Company.
- CIN/LLPIN
U85100HR2013PTC048227
- Company No.
048227
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jan 2013
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Quantum Naturals India Private Limited offer?
Quantum Naturals India Private Limited offers a wide range of products and services, including Cookies, Sugar Free Cookies, Diabetic Herbal Medicine, Anti Diabetic Tea, Diabetic Herbal Tablets & Capsules, Nutraceuticals & Dietary Supplements, Weight Loss Supplement, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Digestive System Drugs & Medicines.
Who are the key members and board of directors at Quantum Naturals India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gurmukh Ghuldu  | Director | 31-Jan-2013 | Current |
| Nirmal Ghuldu | Additional Director | 12-Nov-2021 | Current |
Financial Performance of Quantum Naturals India.
Quantum Naturals India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 114.62% increase. The company also saw a substantial fall in profitability, with a 1041.95% decrease in profit. The company's net worth observed a substantial decline by a decrease of 429%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Quantum Naturals India?
In 2023, Quantum Naturals India had a promoter holding of 63.57% and a public holding of 36.43%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Quantum Naturals India?
Unlock and access historical data on people associated with Quantum Naturals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Quantum Naturals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quantum Naturals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
